Foundations Investment Advisors LLC Increases Stock Position in Omega Healthcare Investors, Inc. (NYSE:OHI)

Foundations Investment Advisors LLC raised its position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 52.1% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 22,650 shares of the real estate investment trust’s stock after purchasing an additional 7,755 shares during the period. Foundations Investment Advisors LLC’s holdings in Omega Healthcare Investors were worth $922,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also added to or reduced their stakes in OHI. Versant Capital Management Inc purchased a new position in Omega Healthcare Investors during the second quarter valued at $26,000. UMB Bank n.a. lifted its position in Omega Healthcare Investors by 353.4% during the third quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust’s stock valued at $27,000 after buying an additional 516 shares during the period. DiNuzzo Private Wealth Inc. purchased a new position in shares of Omega Healthcare Investors in the 3rd quarter worth about $33,000. WFA Asset Management Corp purchased a new position in shares of Omega Healthcare Investors in the 1st quarter worth about $39,000. Finally, V Square Quantitative Management LLC boosted its stake in Omega Healthcare Investors by 49.5% in the 3rd quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust’s stock worth $40,000 after purchasing an additional 323 shares in the last quarter. Hedge funds and other institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Trading Up 0.3 %

Shares of OHI stock opened at $41.73 on Friday. Omega Healthcare Investors, Inc. has a 12-month low of $27.53 and a 12-month high of $41.93. The company has a current ratio of 5.79, a quick ratio of 5.79 and a debt-to-equity ratio of 1.19. The firm’s 50 day moving average is $39.93 and its 200 day moving average is $35.47. The stock has a market capitalization of $10.76 billion, a P/E ratio of 31.85, a P/E/G ratio of 1.33 and a beta of 1.00.

Omega Healthcare Investors (NYSE:OHI) last issued its earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.65 by ($0.20). Omega Healthcare Investors had a return on equity of 8.61% and a net margin of 33.52%. The company had revenue of $252.70 million during the quarter, compared to analysts’ expectations of $205.92 million. During the same quarter in the prior year, the business posted $0.74 EPS. The company’s revenue for the quarter was up 17.5% compared to the same quarter last year. Research analysts expect that Omega Healthcare Investors, Inc. will post 2.69 earnings per share for the current year.

Insider Buying and Selling

In other news, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the transaction, the chief operating officer now owns 100,000 shares in the company, valued at $4,025,000. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other news, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the transaction, the chief financial officer now owns 183,076 shares in the company, valued at $7,357,824.44. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the transaction, the chief operating officer now owns 100,000 shares in the company, valued at $4,025,000. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

OHI has been the subject of a number of analyst reports. BMO Capital Markets raised their price objective on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the company a “market perform” rating in a research note on Monday, October 7th. Berenberg Bank started coverage on shares of Omega Healthcare Investors in a research report on Friday, October 18th. They set a “buy” rating and a $45.00 price target for the company. Truist Financial upped their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a research report on Wednesday, September 4th. Scotiabank lifted their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a report on Monday, August 26th. Finally, Wells Fargo & Company restated an “overweight” rating and issued a $43.00 price target (up previously from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. Eight analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $37.80.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.